Results
Of the 47 patients who completed the trial there were significant improvements with lisinopril for the following endpoints:
- hours with headache reduced by 20%
- days with headache reduced by 17%
- days with migraine reduced by 21%
- headache severity index reduced by 20%
The same endpoints were better for lisinopril when the data was analysed on an intention to treat basis.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.